心脈醫療(688016.SH):子公司擬受讓OMD72.37%股權
格隆匯7月1日丨心脈醫療(688016.SH)公佈,全資子公司 MICROPORT ENDOVASTEC B.V.(簡稱“荷蘭心脈”)擬使用自有資金6,500.00萬美元(以中國人民銀行於 2024 年 7 月 1 日公吿的人民幣匯率中間價計算,摺合人民幣約為46,322.25萬元)受讓 Earl Intellect Limited、Turbo Heart Limited 合計持有的心脈醫療聯營公司 Optimum Medical Device Inc.(簡稱“OMD”)72.37%股權。本次交易完成後,OMD 將成為公司全資子公司。
OMD除全資持有下屬兩家子公司LombardMedicalLimited和LombardMedicalTechnologiesGmbH(統稱為“Lombard”)的股權之外,未實際從事經營業務。其中,LombardMedicalLimited系一家註冊於英國的有限責任公司,主要從事主動脈腔內覆膜支架產品的研發、生產及銷售,核心產品包括AorfixTM腹主動脈覆膜支架系統(簡稱“Aorfix”)及AlturaTM腹主動脈覆膜支架系統(以下簡稱“Altura”);LombardMedicalTechnologiesGmbH系一家註冊於德國的有限責任公司,主要作為Lombard開拓德國市場的銷售公司。Lombard具備滿足歐盟CE、美國FDA、日本PMDA要求的覆蓋產品研發、生產和銷售的質量管理體系,擁有行業經驗豐富、職能覆蓋完善的組織架構及團隊。標的公司在歐美、日本等發達國家擁有20餘年的產品推廣歷史,旗下產品全球已覆蓋23個國家。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.